Mass Spectrometry-Based Serum and Plasma Peptidome Profiling for Prediction of Treatment Outcome in Patients With Solid Malignancies

類似資料

• Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
  著者:: Labots, Mariette, 等
  出版事項: (2018)
• Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
  著者:: Labots, Mariette, 等
  出版事項: (2016)
• Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome
  著者:: Labots, Mariette, 等
  出版事項: (2020)
• Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer
  著者:: van der Mijn, Johannes C., 等
  出版事項: (2014)
• Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors
  著者:: Rovithi, Maria, 等
  出版事項: (2019)